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Metabolomics comprises the methods and techniques that are used to measure the small
molecule composition of biofluids and tissues, and is actually one of the most rapidly
evolving research fields.The determination of the metabolomic profile – the metabolome –
has multiple applications in many biological sciences, including the developing of new
diagnostic tools in medicine. Recent technological advances in nuclear magnetic reso-
nance and mass spectrometry are significantly improving our capacity to obtain more data
from each biological sample. Consequently, there is a need for fast and accurate statistical
and bioinformatic tools that can deal with the complexity and volume of the data gener-
ated in metabolomic studies. In this review, we provide an update of the most commonly
used analytical methods in metabolomics, starting from raw data processing and ending
with pathway analysis and biomarker identification. Finally, the integration of metabolomic
profiles with molecular data from other high-throughput biotechnologies is also reviewed.
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INTRODUCTION
Metabolomics is the study of the metabolite composition of a cell
type, tissue, or biological fluid. The analysis of the complete set
of metabolites – the metabolome – has been present in biologi-
cal research for more than a decade (Patti et al., 2012). However,
major recent advances in the technologies used to extract and
analyze this type of molecular data have revolutionized its applica-
bility in the analysis of organisms and relevant biological processes
(Zhang et al., 2012). To date, metabolomics is envisaged as one of
the major “omics” tools that will most contribute into challeng-
ing research objectives like the personalization of treatments in
medical practice.
The metabolites are the intermediates or end products of
multiple enzymatic reactions and therefore are the most infor-
mative proxies of the biochemical activity of an organism. The
present technologies are allowing the study of tens to hundreds
of metabolites in complex biological samples (Patti et al., 2012).
One of the facts that is most contributing to the rapid growth
of metabolomics is its wide range of applications. These appli-
cations cover diverse research areas like plant biology (Qi and
Zhang,2014),nutrition (Orešicˇ, 2009; Gibbons et al.,2015),animal
breeding (Kühn, 2012), drug discovery (Robertson and Frevert,
2013; Kell and Goodacre, 2014), and the study of human diseases
(Kaddurah-Daouk et al., 2008; Mamas et al., 2011). The biomed-
ical field is actually one of the most active areas of development in
metabolomics, and includes the search for diagnostic and prognos-
tic biomarkers as well as predictors of treatment response (Meyer
et al., 2013; Armitage and Barbas, 2014; Julià et al., 2014). Also in
this field, the use of metabolomics is helping to characterize the
impact of key environmental factors on human health. In this area,
one of the most promising applications is the characterization
of gut–microbiota interactions in humans (Wikoff et al., 2009;
Nicholson et al., 2012).
To date, the two main technical approaches for the generation
of metabolomic data are nuclear magnetic resonance (NMR) and
mass spectrometry (MS; Fuhrer and Zamboni, 2015). NMR is a
fast and highly reproducible spectroscopic technique that is based
on the energy absorption and re-emission of the atom nuclei due
to variations in an external magnetic field (Bothwell and Griffin,
2011). Depending on the atom nuclei being targeted by the applied
magnetic field, different types of metabolomic data are generated.
However, in the analysis of samples of biological origin, hydro-
gen is the most commonly targeted nucleus (1H-NMR), due to its
natural abundance in biological samples. Although less frequent,
other atoms like carbon (13C-NMR) and phosphorus (31P NMR)
are also targeted by NMR, providing additional information on
specific metabolite types (Reo, 2002).
The resulting spectral data in NMR not only allows the quan-
tification of the concentration of metabolites but also provides
information about its chemical structure. The spectral peak areas
generated by each molecule are used as an indirect measure of
the quantity of the metabolite in the sample, while the pattern of
spectral peaks informing on the physical properties of the mole-
cule is used to identify the type of metabolite. The spectral data
obtained with NMR techniques can be referenced to one or two fre-
quency axes. One dimensional NMR (1D-NMR) spectra are based
on a single frequency axis, where the peaks of each molecule are
placed within its resonant frequencies (Figure 1). 1D-NMR is the
most commonly used method in high-throughput metabolomics
studies. Conversely, two dimensional NMR (2D-NMR) spectra are
based on two frequency axis, and its use is often restricted to the
characterization of those compounds that cannot be identified
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FIGURE 1 | Examples of spectra obtained with 1H-NMR and
LC-MS technologies. (A) An example of three spectra obtained with
1D 1H-NMR. (B) A zoomed view of the spectra in (A) in the
2.66–2.74 ppm range. (C) An example of a LC-MS spectrum with
color-coded intensity and referred by the m/z and retention time axes.
(D) The sum of the LC-MS spectrum across the m/z axis. (E) The total
ion chromatogram (i.e., sum of the LC-MS spectrum across the
retention time axis). The colored regions in (E) correspond to the sum
of the LC-MS spectrum limited to the m/z ranges depicted with the
same color in (D).
with 1D-NMR spectra. The second dimension in 2D-NMR allows
to separate otherwise overlapping spectral peaks and, therefore,
gives additional and important information on the chemical prop-
erties of the metabolite (Ward et al., 2007). Although 2D-NMR
generates a large number of different spectra, these can be globally
classified into homonuclear (i.e., 1H–1H-NMR) and heteronuclear
(i.e., 1H–13C or 1H–15N) spectra (Marion, 2013). There are also
different pulse sequences used to generate the 2D-NMR spectra
such as correlation spectrometry (COSY), total correlation spec-
troscopy (TOCSY), and nuclear Overhauser effect spectroscopy
(NOESY). 1D- and 2D-NMR frequency axes are usually refer-
enced by the chemical shift expressed in parts per million (ppm).
The chemical shift is calculated as the difference between the res-
onance frequency and that of a reference substance, subsequently
divided by the operating frequency of the spectrometer (Blümich
and Callaghan, 1995).
Mass spectrometry is an analytical technique that acquires
spectral data in the form of a mass-to-charge ratio (m/z) and a rel-
ative intensity of the measured compounds. For the spectrometer
to generate the peaks signals for each metabolite, the biological
sample first needs to be ionized. The resulting ionized compounds
from each molecule will then generate different peak patterns
that define the fingerprint of the original molecule. A wide range
of instrumental and technical variants are currently available for
MS spectrometry. These variants are mainly characterized by dif-
ferent ionization and mass selection methods (El-Aneed et al.,
2009). In metabolomics, MS is generally preceded by a separa-
tion step. This step reduces the high complexity of the biological
sample and allows the MS analysis of different sets of molecules
at different times. Liquid and gas chromatography columns (LC
and GC, respectively) are the most commonly used separation
techniques (Theodoridis et al., 2011). This chromatographic sep-
aration technique is based on the interaction of the different
metabolites in the sample with the adsorbent materials inside
the chromatographic column. This way, metabolites with differ-
ent chemical properties will require different amounts of time to
pass through the column. The time that each metabolite requires,
called retention time, is used together with the m/z MS values
to generate the two axes of the LC-MS and GC-MS spectral data
(Figure 1).
Frontiers in Bioengineering and Biotechnology | Bioinformatics and Computational Biology March 2015 | Volume 3 | Article 23 | 2
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Alonso et al. Analytical methods in untargeted metabolomics
In the present review, we will describe the processing and
analysis workflows that are commonly used in high-throughput
untargeted metabolomic studies. Untargeted metabolomic stud-
ies are characterized by the simultaneous measurement of a large
number of metabolites from each sample. This strategy, known
as top-down strategy, avoids the need for a prior specific hypoth-
esis on a particular set of metabolites and, instead, analyses the
global metabolomic profile. Consequently, these studies are char-
acterized by the generation of large amounts of data. This data
is not only characterized by its volume but also by its complexity
and, therefore, there is a need for high performance bioinformatic
tools. Conversely, targeted metabolomic studies are hypothesis-
driven experiments and are characterized by the measurement of
predefined sets of metabolites with a high level of precision and
accuracy. This low level of metabolite analysis is not in the scope
of this review, and interested readers are referred to other excellent
specific reviews (Roberts et al., 2012; Putri et al., 2013).
In Figure 2, we show the typical methodological pipeline of
an untargeted metabolomic study. This methodological pipeline
starts with the processing of the spectral data to generate the sam-
ple metabolic information (i.e., metabolic features). The different
methods available to process spectral data are revised in Section
“Spectral Processing.” Together with metabolite-identification
methods, spectral processing methods are highly dependent on the
analytical technique used (e.g., NMR, LC-MS, or GC-MS). Once
the complete set of metabolomic features has been generated, uni-
variant and multivariant data analysis methods can be applied
to investigate: (a) the general structure of the metabolomics data
in the dataset and (b) how the different metabolic features are
related with the phenotypic data associated with the samples.
These analysis methods are reviewed in Section “Data Analysis.”
The analysis of metabolomic data can often be used to build mod-
els that attempt to describe the observed data. Section “Biomarker
Discovery in Metabolomics” of the present review describes the
different strategies for assessing the performance of these models.
In Section “Metabolite Identification and Spectral Databases,” we
address the important technical issue that is the identification of
the metabolites underlying the observed metabolic features (i.e.,
peak areas and spectral bins). The bioinformatic methods that are
actually available for the integration of metabolomic data accord-
ing with biological knowledge are reviewed in Section “Pathway
and Network Analysis of Metabolomic Data.” Finally, the differ-
ent methodologies that allow the integration of metabolomics
data with other omics data (e.g., genomics or transcriptomics) are
reviewed in Section “Integration of Omics Data.” Table 1 shows
a list of the freely available tools that are most commonly used
in metabolomic analysis. These tools provide different method-
ological options for spectral processing, data analysis, or pathway
analysis.
SPECTRAL PROCESSING
Spectral processing is a methodological approach aimed at accu-
rately identifying and quantifying the features in the sample spec-
tra of a metabolomics study (Figure 3). Metabolomic spectra
are sequentially or jointly processed until a final set of feature
quantifications is obtained. Spectral processing is also necessary
to guarantee that each final measurement will refer to the same
metabolomic feature in all samples. The data resulting from spec-
tral processing is generally arranged in a feature quantification
matrix (FQM) that contains the quantification of the metabolic
features of all the analyzed samples and that will be used as input
for subsequent statistical analysis.
SPECTRAL PRE-PROCESSING
In order to improve the signal quality and reduce possible biases
present in the raw data, several pre-processing steps are usually
applied. In NMR- and MS-based spectra, baseline correction is
used to remove low frequency artifacts and differences between
FIGURE 2 | Analysis workflow in untargeted metabolomic studies. This figure shows the different steps of the metabolomic analysis pipeline.
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Table 1 | List of tools available for metabolomics spectral processing and data analysis.
Tool Type Target Featuresa Website Reference
MetaboAnalyst2 Web MS and NMR 1–7 http://www.metaboanalyst.ca/ Xia et al. (2012)
XCMS R MS 1–3 http://metlin.scripps.edu/xcms/ Smith et al. (2006)
MetSign MatLab MS 1–3 http://metaopen.sourceforge.net/ Lommen and Kools (2012)
XCMS online Web LC-MS 1–4 https://xcmsonline.scripps.edu/ Tautenhahn et al. (2012b)
MAVEN Application LC-MS 1–7 http://genomics-pubs.princeton.edu/mzroll Melamud et al. (2010)
mzMine2 Application LC-MS 1–5 http://mzmine.sourceforge.net/ Pluskal et al. (2010)
MAIT R LC-MS 1–5 http://b2slab.upc.edu/software-and-downloads Fernández-Albert et al. (2014)
OpenMS Application LC-MS 1–3 http://open-ms.sourceforge.net/ Sturm et al. (2008)
Metabolome express Web GC-MS 1–5 https://www.metabolome-express.org/ Carroll et al. (2010)
Metabolite detector Application GC-MS 1–4 http://md.tu-bs.de/ Hiller et al. (2009)
MetDAT Web MS 1–5 http://smbl.nus.edu.sg/METDAT2/ Biswas et al. (2010)
FOCUS MatLab NMR 1–4 http://www.urr.cat/FOCUS/ Alonso et al. (2013)
Automics Application NMR 1–2, 5 https://code.google.com/p/automics/ Wang et al. (2009)
Bayesil Web NMR 1–4 http://bayesil.ca/ Ravanbakhsh et al. (2014)
Speaq Application NMR 1–2, 5 https://code.google.com/p/speaq/ Vu et al. (2011)
MetaboLab Application NMR 1–2, 5 http://www.nmrlab.org.uk/ Ludwig and Gunther (2011)
rNMR R NMR 8 http://rnmr.nmrfam.wisc.edu/ Lewis et al. (2009)
MetaboMiner Application NMR 8 http://wishart.biology.ualberta.ca/metabominer/ Xia et al. (2008)
Muma R – 5 http://cran.r-project.org/web/packages/muma Gaude et al. (2013)
MetaXCMS R MS and NMR 5 http://metlin.scripps.edu/metaxcms/ Tautenhahn et al. (2010)
BATMAN R NMR 3–4 http://batman.r-forge.r-project.org/ Hao et al. (2012)
AStream R LC-MS 4 http://www.urr.cat/AStream/AStream.html Alonso et al. (2011)
Camera R LC-MS 4 http://metlin.scripps.edu/xcms/ Kuhl et al. (2011)
MetaboHunter Web NMR 4 http://www.nrcbioinformatics.ca/metabohunter/ Tulpan et al. (2011)
MetScape Application – 6–7 http://metscape.ncibi.org/ Gao et al. (2010)
IMPaLA Web – 6–7 http://impala.molgen.mpg.de/ Kamburov et al. (2011)
MetExplore Web – 6–7 http://metexplore.toulouse.inra.fr/ Cottret et al. (2010)
MetPA Web – 6–7 http://metpa.metabolomics.ca/ Xia and Wishart (2010a)
Cytoscape Application – 7 http://www.cytoscape.org/ Smoot et al. (2011)
Vanted Application – 7 http://vanted.ipk-gatersleben.de/ Rohn et al. (2012)
Paintomics Web – 7 http://www.paintomics.org/ García-Alcalde et al. (2011)
This table provides a complete and updated list of the open-source software that is commonly used in the untargeted analysis of metabolomic data.
aThis column refers to the features included in the tool: spectral pre-processing (1), spectral/peak alignment (2), peak detection (3), metabolite identification (4), data
analysis (5), pathway analysis (6), pathway visualization (7), and 2D-NMR analysis (8).
samples that are generated by experimental and instrumental vari-
ation (Dietrich et al., 1991; Smith et al., 2006; Xi and Rocke, 2008;
Zhang et al., 2010). After this, the application of high-frequency
filters may be necessary to remove the electronic noise present in
the data that is generated by the measurement equipment.
FEATURE-DETECTION
The objective of the feature-detection step is to identify and quan-
tify the features present in the spectra. Peak-based methods are
the most common algorithmic choice for feature-detection in MS-
based studies (Gika et al., 2014; Niu et al., 2014; Rafiei and Sleno,
2015). These methods detect the peaks across the spectrum and
integrate their areas to provide a quantification of the underlying
metabolite. In this approach, spectral alignment is also generally
applied either before or after peak detection. In NMR studies,
binning-based approaches have been commonly used to detect fea-
ture peaks in complex biological samples. However, these methods
perform poorly compared to peak-based methods, particularly in
those cases where there is significant spectral unalignment, or in
those cases where multiple peaks from different metabolites are
captured by the same spectral bin (Vu and Laukens, 2013). For
these reasons, peak-based methods are increasingly being used in
NMR-based studies (Wishart, 2008). Nonetheless, there have been
recent developments in binning algorithms, particularly in the
detection of the optimal binning boundaries that have improved
the performance of this feature-detection approach (Sousa et al.,
2013).
Peak overlap is also a common problem in NMR-based stud-
ies. Overlapping peaks are treated as one same feature both in
binning and peak-based approaches. Consequently, the results
obtained from the analysis of these variables can be often hard
to interpret. To attempt to solve this problem, spectral decon-
volution methods have been developed (Hao et al., 2014). These
methods, which are based on the fitting to metabolite spectral tem-
plates, are able to extract independent metabolite quantifications
from a set of overlapping peaks. The main disadvantage of this
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FIGURE 3 | Features of spectral data. This figure shows the different
types of features that can be extracted from spectral data and used for data
analysis.
type of algorithms, however, is that they depend on the existence
of spectral libraries of each metabolite and, therefore, they are
unable to quantify peaks arising from previously uncharacterized
metabolites.
Peak detection
The most commonly used peak detection algorithms analyze each
sample spectrum independently (Tautenhahn et al., 2008, 2012b;
Pluskal et al., 2010). These methods are based on two analytical
steps (Yang et al., 2009). In the first step, the spectra are smoothed.
For this objective, multiple different filters are available (i.e., mov-
ing average, Gaussian, Savitzky-Golay. . .; Yang et al., 2009). From
these, however, the Wavelet transform-based filters have demon-
strated a superior performance, although at the expense of a higher
computation time (Du et al., 2006; Tautenhahn et al., 2008). This
performance improvement is mainly due to the ability of the
Wavelet transform to work with the unequal peak widths that
characterize metabolomic spectra. In the second step, the differ-
ent metabolite peaks are identified using one or multiple detection
thresholds. These thresholds are applied to different parameters
such as the signal-to-noise ratio, the intensity, or the area of
each peak from the resulting filtered spectra (Yang et al., 2009).
In metabolomics studies involving large numbers of samples, a
frequency filter (i.e., consensus peak signal), can be also applied so
that only those peaks that are present in a minimum percentage of
samples are selected for downstream analysis.
Spectral alignment
Spectral alignment is one of the main processing steps in
metabolomic studies involving multiple samples. When analyz-
ing multiple spectra, the position of the peaks corresponding to
the same metabolic feature may be affected by non-linear shifts. In
NMR-based studies, these shifts are observed in the ppm axis and
are usually introduced by differences in the chemical environment
of the sample like ionic strength, pH, or protein content (Weljie
et al., 2006; Xiao et al., 2009). In MS-based studies, peak shifts are
mainly observed across the retention time axis, and are generally
associated with changes in the stationary phase of the chromato-
graphic column (Burton et al., 2008). Spectral alignment methods
must be therefore applied to correct this undesired variability in
the samples that can profoundly affect the quality of the study.
Spectral alignment algorithms can be divided in two main groups:
(i) spectral alignment methods, where the spectral data is aligned
before peak detection and (ii) peak-based alignment methods,
where spectral peaks are aligned across samples once they have
been detected using their coordinates (ppm in NMR, and m/z and
retention time in LC/GC-MS).
Spectral alignment methods are classified into warping and seg-
menting methods. Warping methods are based on the application
of a non-linear transformation to the ppm (in NMR spectra) or the
retention time (in LC/GC-MS) axis in order to maximize the cor-
relation between the spectra. The alignment is then performed by
either stretching or shrinking spectral segments to reach this cor-
relation maximization. Among these methods, correlation opti-
mized warping (COW) and dynamic time warping (DTW) are the
most commonly used. COW is a segmental alignment method that
aligns one sample spectrum toward a reference spectrum (Tomasi
et al., 2004). This is done by splitting the original sample and refer-
ence spectra into small segments, and by separately aligning each
pair of segments. Alignment is performed through dynamic pro-
graming in such a way that limited changes in segment lengths are
allowed. This way, the overall correlation between both spectra is
effectively maximized. In the particular case of crowded spectral
regions with large peak shifts, COW has demonstrated to per-
form particularly well compared to other methods. An alternative
to COW method, DTW is a spectral alignment method (Tomasi
et al., 2004) that is also based on dynamic programing, and where
a warping path is computed to which the connected data points
of each spectrum are equivalent. During this last decade, other
warping approaches have been developed (Eilers, 2003; Forshed
et al., 2003; Lee and Woodruff, 2004; Clifford et al., 2009).
Spectral segmenting methods differ from spectral warping
methods in that alignment is performed by applying a constant
shift to all the spectral points. These methods either align the
overall spectra or split the spectra into smaller segments and
independently align each resulting segment. The Icoshift algo-
rithm (Savorani et al., 2010) is one of the most commonly used
segmentation methods, and is based on the convergence toward
a reference signal. This convergence is performed by applying
shifts that maximize the segment spectral correlation, which is
normally computed using the fast Fourier transform (FFT) to
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speed up the required calculations (Wong et al., 2005). Icoshift
and other correlation-based methods can also be combined with
automatic segmentation methods (Veselkov et al., 2008), which
are able to optimally split the spectra in order to improve the
alignment of the resulting spectral segments. However, the use
of a reference spectrum has several disadvantages. Very recently,
the RUNAS algorithm implemented in the FOCUS processing
workflow (Alonso et al., 2013) has provided a spectral segmenting
method that avoids the use of a reference spectrum. Instead, the
FOCUS method uses the information from the different sample
spectra to iteratively maximize the inter-sample weighted-mean
correlation. This approach has shown that avoiding the use of a
reference spectrum is a powerful strategy to avoid many of the
analytical biases derived from its use. These biases are mainly due
to the fact that the reference spectrum may not be representative
of the spectral diversity present in the samples. FOCUS alignment
algorithm has also shown that an appropriate spectral transfor-
mation prior to alignment avoids the biases due to the presence of
multiple peaks in the same alignment window. Under these con-
ditions, the methods based in correlation maximization without
prior transformation are more prone to align the most relevant
peak of each sample regardless of whether they correspond to the
same metabolic feature or not.
Fast Fourier transform-based segmenting methods such as
RAFFT, Icoshift, and FOCUS not only are able to process large
metabolomics datasets in a reduced amount of time, but also
have shown to perform better than spectral warping methods
(Giskeødegård et al., 2010; Savorani et al., 2010; Alonso et al.,
2013; Jiang et al., 2013). Within the different segmenting meth-
ods, reference-free methods avoid the biases introduced by using
reference spectra, but at a cost of being more computationally
intensive.
Of relevance, the results reported by several performance com-
parison studies using either NMR or MS have demonstrated that
spectral alignment algorithms have a good performance irrespec-
tive of the analytical technique that has been used (MS or NMR;
Van Nederkassel et al., 2006; Giskeødegård et al., 2010). Con-
sequently, methods that were initially developed to align NMR
spectra are also applied to align MS spectra and vice versa.
Compared to the warping and segmentation alignment meth-
ods, peak-based methods are applied after peak detection. In these
methods, peak coordinates are used to perform the alignment.
This type of method is implemented in the XCMS software (Taut-
enhahn et al., 2012b), one of the most commonly used methods
to process data from LC-MS studies. Given that the shifts along
the m/z axis are minimal and the m/z axis has a high resolution,
the data can be safely binned in m/z intervals, and peak align-
ment performed on each bin along the chromatographic time.
The XCMS algorithm computes the retention time boundaries
within which the observed peaks are expected to represent the
same metabolomic feature across the different samples. The com-
putation of these retention time boundaries is performed by using
a kernel density estimator. Another common alignment method
used in MS is the RANSAC algorithm (Pluskal et al., 2010). In this
approach, the corresponding peaks across samples are identified
by using a LOESS regression on different retention times and m/z
windows.
FEATURE NORMALIZATION
In order to perform an accurate quantification of the features
in a metabolomic analysis, a data normalization step is generally
required. The objective of normalization is to remove undesired
systematic biases, so that only biologically relevant differences
are present in the data. This procedure is crucial when analyzing
complex biofluids like blood, where the differences in metabolite
concentration between samples can be high, and the introduction
of internal standards is complicated. Although multiple statistical
models have been developed for this objective (Craig et al., 2006;
Kohl et al., 2012), the two perhaps most commonly used methods
are the use of endogenous stable metabolites (like creatinine in
urine) and the use of the total spectral area [i.e., area under the
curve (AUC); Weljie et al., 2006; Rasmussen et al., 2011].
DECONVOLUTION METHODS IN TARGETED ANALYSIS
One of the main limitations for the quantification of metabolomic
features is the overlap between peaks from different metabolites.
NMR and GC-MS spectra are particularly prone to this type of
bias. In order to deal with this technical issue, several method-
ological approaches have been developed. These approaches are
based on spectral deconvolution (Chylla et al., 2011; Astle et al.,
2012; Du and Zeisel, 2013; Hao et al., 2014), a signal processing
technique that estimates the relative area corresponding to each
individual peak when multiple peaks overlap within the same
spectral region (Figure 4). However, an important limitation of
deconvolution methods is that prior knowledge of the compounds
FIGURE 4 | Spectral deconvolution. This figure shows how spectra (gray
shaded area) can be decomposed (i.e., deconvoluted) in multiple
components corresponding to different metabolite compounds.
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present in the mixture is required. Additionally, the use of these
methods in untargeted metabolite studies is yet not possible due
to computational intractability (Hao et al., 2014).
The usual input data for these methods is the spectral data from
the study and at template library containing the reference peak
patterns of each metabolite. Currently, there are multiple methods
available for spectral deconvolution of NMR data (Chylla et al.,
2011; Zheng et al., 2011; Astle et al., 2012; Hao et al., 2014) and
they are mostly based on Bayesian model selection. Among them,
BATMAN (Hao et al., 2012) is one of the most frequently used,
providing a rich and user-friendly interface and a complete pro-
tocol to perform this type of analysis (Hao et al., 2014). BATMAN
is an open-source software and its performance has been demon-
strated to be very similar to that of the NMR Suite software package
(Chenomx Inc., Edmonton, AB, Canada; Weljie et al., 2006), a
proprietary software that is considered a gold standard for NMR
metabolomics (Chenomx Inc., Edmonton, AB, Canada; Weljie
et al., 2006). The NMR Suite itself provides a semi-automated tool
for spectral deconvolution which allows interactive fitting of the
metabolite peaks to the reference metabolite spectra. The major
disadvantage of this tool is the large amount of time required to
process large sample datasets and the need of highly skilled data
analysis specialists.
GC-MS methods for spectral deconvolution are mostly based
on unsupervised approaches that do not require the prior knowl-
edge of the compounds presents in the sample (Stein, 1999; Hiller
et al., 2009; Ni et al., 2012). These approaches are mainly based
on three steps, namely: (a) noise analysis for selecting the spectral
segments to be deconvoluted, (b) component perception for iden-
tification of the individual components present in each segment,
and (c) deconvolution for fitting the individual components to
the overall spectral shape. Du et al. provide an extensive review of
these methods (Du and Zeisel, 2013).
DATA ANALYSIS
Once the metabolite features are robustly quantified, there are
multiple univariate and multivariate statistical methods that can
be used to perform the desired study analysis. These groups of
techniques are commonly known as chemometric methods (Mad-
sen et al., 2010) and usually require some degree of expertise to
be conveniently applied. In the following sections, we define the
most commonly used metabolomic features, and we describe the
most commonly used chemometric methods.
METABOLOMIC FEATURES
After applying the adequate pre-processing methods,metabolomics
data is usually reduced to a FQM. In this data representation, rows
correspond to the samples and columns correspond to the different
metabolomic features. Each metabolomic feature is intrinsically
related to the concentration of a particular metabolite. Depending
on the analytical technique and the spectral processing workflow
that have been used, different metabolomic features are used as
input for data analysis (Figure 3):
• Spectral peak areas: one of the most commonly used features
in high-throughput metabolomics data (NMR-based or MS-
based). They are computed through the integration of the peaks
identified and aligned using the methods described in the pre-
vious section (see Spectral Pre-Processing to Deconvolution
Methods in Targeted Analysis). Once this data has been analyzed,
the identification of the metabolites representing the relevant
peaks is required in order to provide biological meaning to
the results. Metabolite-identification methods are reviewed in
Section “Metabolite Identification and Spectral Databases.”
• Metabolite concentrations: in contrast to the previous features,
metabolite identification can be performed prior to data analysis
in order to obtain absolute or relative metabolite concentra-
tions to be used as input for data analysis (Wishart, 2008; Zhou
et al., 2012). This type of features allow both to reduce the
high redundancy of peak areas (i.e., one metabolite is often
represented by multiple spectral peaks), and to provide biolog-
ical significance to all the analyzed features. The most com-
mon metabolite-identification methods are reviewed in Section
“Metabolite Identification and Spectral Databases.”
• Spectral bin areas: in addition to peak areas and metabolite con-
centrations, spectral bins (or also buckets) are also commonly
used features in NMR-based studies. This technique consists of
dividing the spectra into evenly spaced regions that are later inte-
grated to obtain the corresponding spectral bin areas. In order
to mitigate problems such as peaks lying in two consecutive
integration regions, some methods have implemented uneven
binning algorithms like dynamic adaptative binning (Ander-
son et al., 2011), Gaussian binning (Anderson et al., 2008),
and adaptative intelligent binning (De Meyer et al., 2008). This
feature estimation approach has, however, some inherent disad-
vantages produced by the presence of uninformative features in
the spectra (i.e., spectral areas without spectral peaks) and the
lack of inter-sample feature correspondence when spectra are
heavily affected by unalignment (e.g., urine samples with large
pH variability).
UNIVARIATE ANALYSIS METHODS
Univariate methods analyze metabolomic features independently.
They are common statistical analysis approaches and, therefore,
their main advantage is their ease of use and interpretation. How-
ever, their main disadvantage is that they do not take into account
the presence of interactions between the different metabolic fea-
tures. The metabolomic data obtained from biological samples is
often very complex with the presence of correlations between fea-
tures from the same metabolite and correlations between metabo-
lites from the same pathway. Also, the effect of potential confound-
ing variables like gender, diet, or body mass index is not taken into
account by these analysis methods, increasing the probability of
obtaining false positive or false negative results (Winnike et al.,
2009; Rasmussen et al., 2011; Townsend et al., 2013).
Several univariate analysis methods are available for
metabolomic data analysis. The selection of the method will
depend on the statistical properties of the feature distribution
(Broadhurst and Kell, 2006; Vinaixa et al., 2012). For example,
when assessing differences between two or more groups, para-
metric tests such as Student’s t -test and ANOVA are commonly
applied, provided that normality assumptions are conveniently
verified. The latter can be confirmed using the Kolmogorov–
Smirnov normality test or Bartlett’s homogeneity of variances
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test. In those cases where normality of the data cannot be
assumed, non-parametric tests such as Mann–Whitney U test or
Kruskal–Wallis one-way analysis of variance are preferable.
In addition to choose the most appropriate statistical analysis
test, another important consideration in metabolomic data analy-
sis is the multiple testing problem. In most metabolomic studies,
a large number of metabolomic features are analyzed simulta-
neously and, therefore, the probability of finding a statistically
significant result by chance (i.e., false positive) is high. In order to
control for this multiple testing issue, several correction methods
are available. Each method is characterized by a particular balance
between avoiding false metabolite associations (i.e., false positives)
and prevents discarding true associations (i.e., false negatives).
Depending on the study design, researchers might decide to use a
more or less conservative approach. The Bonferroni correction is
perhaps the most conservative multiple test correction approach,
where the number of type I errors (false positives) regarding to
the total number of hypotheses tested [i.e., defined as familywise
error rate (FWER)] is minimized at the expense of increasing type
II errors (false negatives). In the Bonferroni correction, the signif-
icance level for one hypothesis (i.e., alpha value), is divided by the
number of hypotheses tested simultaneously. Although a very con-
servative approach, especially when the hypotheses tested are not
independent, many researchers advocate its use in metabolomic
studies (Broadhurst and Kell, 2006). Recently, Chadeau-Hyam
et al. assessed the metabolome-wide significance level (MWSL)
for biomarker identification in urine using a permutation-based
method to estimate the correct FWER (Chadeau-Hyam et al.,
2010). Their method took into account metabolite collinearity and
reported that a conservative estimate of the independent number
of tests is 35% of the performed tests. This result indicates that
the Bonferroni multiple test correction method might be over
conservative.
Other less conservative multiple test correction methods are
however available and are mostly based on the minimization of
the false-discovery rate (FDR; Benjamini and Hochberg, 1995).
While Bonferroni and other FWER-based methods minimize the
probability of at least one false positive in the overall set of tests,
FDR-based methods minimize the expected proportion of false
positives on the total number of positives (Van Den Oord, 2008).
Most of these methods have been extensively used for the analy-
sis of gene-expression microarray data, where thousands of genes
are tested in parallel (Reiner et al., 2003; Jung, 2005; Xie et al.,
2005). In untargeted metabolomic studies, where large numbers
of metabolites are simultaneously analyzed, and where it is also
expected that more than one or two of these biomarkers will be
associated, the use of less strict multiple correction methods like
FDR methods might be more useful.
MULTIVARIATE ANALYSIS METHODS
In contrast to univariate methods, multivariate analysis methods
take into account all the metabolomic features simultaneously
and, consequently, they can identify relationship patterns between
them. These pattern-recognition methods can be classified into
two groups: supervised and unsupervised methods. In unsuper-
vised analysis methods, the similarity patterns within the data are
identified without taking into account the type or class of the
study samples. In supervised methods, the sample labels are used
in order to identify those features or features combinations that are
more associated with a phenotype of interest. Supervised methods
are also the basis for building prediction models.
Unsupervised methods
Unsupervised methods are often applied to summarize the com-
plex metabolomic data. They provide an effective way to detect
data patterns that are correlated with experimental and/or biolog-
ical variables. Principal component analysis (PCA) is the most
commonly used unsupervised method in metabolomic studies
(Wold et al., 1987; Bro and Smilde, 2014). PCA is based on the
linear transformation of the metabolic features into a set of lin-
early uncorrelated (i.e., orthogonal) variables known as principal
components. This decomposition method maximizes the variance
explained by the first component while the subsequent compo-
nents explain increasingly reduced amounts of variance. At the
same time, PCA minimizes the covariance between these compo-
nents (i.e., they are independent of each other). After applying
the PCA method, a set of loading vectors and score vectors are
obtained. The loading vectors represent the principal components,
and each vector coefficient corresponds to the individual contribu-
tion of each variable to the principal component. The score vectors
represent the projection of each sample onto the new orthogonal
basis. Plotting these sample scores over the first principal com-
ponents is a convenient way of summarizing the global dataset,
since normally these first principal components capture most of
the variability in the dataset. PCA is also used in metabolomics
studies to assess data quality, since it can identify sample outliers
or reveal hidden biases in the study. For example, PCA has been
used in several studies to determine the impact of technical varia-
tion in the analysis of metabolic profiles (Gika et al., 2008; Winnike
et al., 2009; Rasmussen et al., 2011; Yin et al., 2013).
Other unsupervised methods like hierarchical clustering analy-
sis (HCA) and self-organizing maps (SOMs) have also been
applied to metabolomic data. These methods can be particularly
suitable to detect non-linear trends in the data that are not conve-
niently covered by PCA. SOMs have been used in metabolomics
studies to visualize metabolic phenotypes and feature patterns as
well as to prioritize the metabolites of interest based on their sim-
ilarity (Kohonen et al., 2000; Meinicke et al., 2008; Mäkinen et al.,
2008; Goodwin et al., 2014). HCA is also a powerful clustering and
visualization tool that provides a clustering procedure at the fea-
ture and sample levels according to a predefined distance measure
(Brauer et al., 2006; Sreekumar et al., 2009).
Supervised methods
Supervised methods are used to identify metabolic patterns that
are correlated with the phenotypic variable of interest while down-
weighting the other sources of variance. These methods are also
the basis for building classifiers based on metabolomic features
(Xia et al., 2013). Partial least squares (PLS; Fonville et al., 2010) is
one of the most widely used supervised method in metabolomics.
It can be used either as a regression analysis (i.e., quantitative
variable of interest) or as a binary classifier (PLS-DA; i.e., binary
variable of interest). Unlike PCA, PLS components do not maxi-
mize the explained dataset variance but the covariance between
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the variable of interest and the metabolomic data. Therefore,
the feature coefficients (loadings) of PLS components represent
a measure of how much a feature contributes to the discrimi-
nation of the different sample groups. However, one weakness
of PLS is that some metabolic features that are not correlated
with the variable of interest can influence the results. In order to
deal with this problem, orthogonal PLS (O-PLS; Trygg and Wold,
2002) were developed. O-PLS models evolved from PLS mod-
els and factorize the data variance into two components: a first
component which is correlated with the variable of interest and
a second uncorrelated component (i.e., orthogonal). Classifica-
tion of metabolomics samples is commonly performed by fitting
the discriminant analysis versions of PLS and O-PLS models (i.e.,
PLS-DA, O-PLS-DA; Kemsley, 1996; Bylesjö et al., 2006).
The performance of PLS and O-PLS models has been exten-
sively compared but, to date, there is no agreement as to which
of the two methods is superior (Tapp and Kemsley, 2009). In the
last years, however, a progressive move from the use of PLS mod-
els to O-PLS models has been observed in the metabolomics field
(Fonville et al., 2010).
Support vector machines (SVMs) are another class of super-
vised analysis methods to build classifiers based on metabolomic
data (Mahadevan et al., 2008; Kim et al., 2010; Luts et al., 2010).
Although classifiers based on SVM are harder to interpret, they are
able to manage the presence of non-linear relations between the
metabolomic data and the variable of interest.
Multiway methods for longitudinal metabolomic data
There is also a wide range of methods that are designed to provide
a comprehensive interpretation of the metabolic changes accord-
ing to the organization of the analyzed samples (i.e., samples from
different tissues or corresponding to time series in a longitudi-
nal study). These methods decompose the original multiway (i.e.,
multi-dimensional) data matrix into a set of easily interpretable
factors. In NMR studies, two of the most commonly used meth-
ods are parallel factor analysis (PARAFAC) and multivariate curve
resolution (MCR). The input data for these methods is commonly
a three dimensional (3D) matrix with coefficients cijk (where i
represents a metabolic feature, j the analyzed individual, and k
the tissue from which the sample was extracted or the sample
extraction time-point). The PARAFAC analysis of a 3D matrix
generates three loading matrices that capture the contributions
of each metabolic feature, of each individual, and of each tissue
type or time-point. Alternatively, MCR analysis decomposes the
3D matrix into a set of two factors which contain the contribu-
tions of each metabolic feature and each analyzed sample. To do
this, the 3D matrix must be fitted in a 2D matrix, where the differ-
ent metabolic features are arranged on the first dimension while
the each individual and tissue/time-point are arranged on the sec-
ond dimension (Peré-Trepat et al., 2007; Karakach et al., 2009;
Montoliu et al., 2009; Martin et al., 2010).
BIOMARKER DISCOVERY IN METABOLOMICS
One of the most promising applications of metabolomics in
the medical sciences is the identification of biomarkers. New
metabolomic biomarkers are usually determined using supervised
analysis models since they are capable to aggregate the evidence of
multiple metabolites. The usefulness of the resulting classification
models must be then evaluated in order to consider their use in
real clinical settings. Performance assessment and model valida-
tion are crucial analytical steps for the evaluation of metabolomic
classification models.
PERFORMANCE ASSESSMENT
Performance assessment measures how well the outcome predicted
by our model matches the real outcome. Several complemen-
tary measures are available to assess the classifier performance:
predictive accuracy (percentage of correctly classified subjects),
sensitivity (percentage of true positives that are correctly classi-
fied), and specificity (percentage of true negatives that are correctly
classified). These three measures allow the assessment of the classi-
fier performance given a fixed decision boundary. However, these
performance measures tend to be dependent on the outcome
prevalence and on the decision boundary chosen (Xia et al., 2013).
The receiver operating characteristic (ROC) curve avoids this type
of bias and is the most used performance assessment method.
ROC curve estimation is a non-parametric procedure consisting
of the comparison of specificity against sensitivity according to
a specific decision boundary. ROC curves are often summarized
by the AUC metric. The AUC metric gives the probability that a
classifier will rank a randomly chosen positive sample higher than
a randomly chosen negative one. Therefore, a perfect classifier will
obtain AUC= 1 while a random classifier will obtain AUC close to
0.5. An AUC >0.7 is often considered the minimal performance
for a biomarker test to be considered clinically useful (Xia et al.,
2013). In addition to the overall performance assessment using
the AUC metric, the ROC curves can also be used to determine
the optimal decision boundary for the classifier (Xia et al., 2013).
ROC curve estimation is a common analysis and therefore, multi-
ple tools are available for ROC-based performance evaluation like
the R packages ROCR (Sing et al., 2005) and pROC (Robin et al.,
2011), as well as the ROCCET (Xia et al., 2013) web application.
MODEL VALIDATION
When designing classification models, a validation step is required
to estimate how well the classification model will perform when
applied to new samples. This step is particularly important when
using small sample sizes in order to discard model overfitting.
Two main approaches are available for performing this task:
permutation testing and cross-validation (Westerhuis et al., 2008).
The aim of the permutation-based validation is to measure the
performance of the predictor model by determining the probabil-
ity of observing an equal or better performance by pure chance.
This analysis is performed by estimating the null distribution of
the performance measures (i.e., AUC) under the assumption that
no differences exist between sample groups. This is done by ran-
domly permuting multiple times the sample group classes (e.g.,
case-control) and calculating the statistic under each permuted
dataset. Once computed, the performance measures of the true
model (i.e., based on the real sample status) should lie outside
the chosen confidence intervals (e.g., 95 or 99%) of the estimated
null distributions in order to be considered significant. In contrast
with the permutation approach, cross-validation approaches esti-
mate the predictive performance of a classifier using an iterative
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approach. At each round of cross-validation, the total sample is
split into a training group and a testing group. In the former
group, the predictor model is built using a specific set of para-
meters. The performance of this model is then evaluated using
the remaining group of samples. This procedure is repeated sev-
eral times so that all the samples have been used once as a testing
group. Averaging these results we will obtain an unbiased esti-
mate of the performance of the predictor. The size of the testing
sample can be composed by several samples (i.e., n-fold cross-
validation) or can be as small as a single individual (i.e., leave-one
out cross-validation). This approach provides a good measure of
how data overfitting affects to the computed model. When the
used models require optimization (i.e., optimal number of PLS/O-
PLS components to be used) a double cross-validation schema is
usually required: a first cross-validation step is applied to opti-
mize the model and a second step for assessing the model quality
(Westerhuis et al., 2008; Szymanska et al., 2012). The double cross-
validation schema requires the dataset to be iteratively split in two
sets S1 and S2. In the first step, the S1 set is randomly divided into
two subsets S11 and S12, where S11 is used to compute models
with different number of components and the S12 set is used to
evaluate the prediction power of each model. This procedure is
repeated until all the samples in S1 have been once in the S12
set, and the model with the lowest prediction error is selected. In
the second step, the S2 set is used to assess the performance of the
optimal model as computed in step one. This global analysis is per-
formed recursively by randomly splitting the global dataset in sets
S1 and S2 until all the samples have been once in S1. Further details
on the different types of cross-validations are described in more
detail elsewhere (Westerhuis et al., 2008; Szymanska et al., 2012).
METABOLITE IDENTIFICATION AND SPECTRAL DATABASES
Metabolite identification is one of the major challenges of high-
throughput metabolomic analysis. This step is indispensable
to confer a biological meaning to the associated features in a
metabolomic study. In MS-based studies, the common metabolite-
identification approach is based on querying metabolomic data-
bases for the neutral molecular mass values of the identified peaks
using a tolerance window. The neutral molecular mass is inferred
from the peak m/z value, and depends on the chemical nature of
the identified peak (i.e., ionization mode and ionization adduct).
Assuming no prior knowledge, each peak m/z value can lead to
multiple plausible neutral molecular masses that can represent
different ionization adducts (H+, Na+, K+, . . .). This multiplicity
often results in a high number of false positive identifications. In
order to reduce false positives, several methods have been devel-
oped. AStream and Camera are methods designed to identify
isotopic and adduct patterns in order to reduce data complexity
in MS experiments (Alonso et al., 2011; Kuhl et al., 2011). Using
these approaches, the chemical nature of each selected ion peak is
estimated, and only one neutral mass is inferred from each iden-
tified pattern. Using these methods has the added advantage of
improving the ascertainment of true biological compounds.
In NMR-based studies, automatic metabolite identification is
commonly performed by matching the measured NMR peaks
against a set of reference metabolite patterns. Each metabolite
reference spectrum is defined by one or multiple peaks, which are
characterized by their ppm positions and their relative intensities.
MetaboHunter is an online tool for identifying compounds by
matching the reference peak positions against the list of detected
peak positions (Tulpan et al., 2011). However, this approach can
lead to high false positive rates, since it only uses one peak para-
meter to match reference peaks. The MetaboHunter approach has
been superseded by more recent methods based on the valid clus-
ter concept (Mercier et al., 2011; Jacob et al., 2013). In addition
to using the ppm position, these methods include peak intensities
and inter-sample intensity correlation as parameters for matching
data peaks to reference peaks. The NMR analysis workflow imple-
mented in FOCUS follows this same metabolite-identification
approach, with the added advantage that it also accounts for
the presence of missing peaks generated by spectral overlapping
(Alonso et al., 2013).
Metabolite spectral databases are essential for metabolite iden-
tification. The quality of the stored data as well as the number of
metabolite spectra available in these databases is critical for the
performance of identification algorithms. During the last years,
multiple databases have been developed (Table 2) and the number
of available metabolite reference spectra is continuously growing
(Ellinger et al., 2013; Fukushima and Kusano, 2013). The Human
Metabolome Database (HMDB) is perhaps the most extensive
public metabolomic spectral database to date (Wishart et al.,
2013). The HMDB stores >40,000 different metabolite entries,
with exhaustive biological metadata and MS/NMR spectral ref-
erences. In addition to spectral databases, several studies have
also contributed to characterize the metabolome of multiple types
of samples. Many of these reference studies are also exceptional
resources of high quality data associated with the biofluid, tissue,
or cell type of interest (Wishart et al., 2008; Psychogios et al., 2011;
Bouatra et al., 2013).
PATHWAY AND NETWORK ANALYSIS OF METABOLOMIC
DATA
Pathway and network analysis approaches increase the informa-
tion generated by metabolomic studies. Both approaches exploit
the relational properties present in metabolomic data. Pathway
analysis uses prior biological knowledge to analyze metabolite
patterns from an integrative point of view. Alternatively, net-
work analysis uses the high degree of correlation existing in
metabolomics data to build metabolic networks that character-
ize the complex relationships existing in the set of measured
metabolites.
PATHWAY ANALYSIS
Until very recently, when analyzing metabolomic data no prior
knowledge regarding metabolite relationships could be assumed.
During the last years, however, the biological knowledge avail-
able for metabolomics studies has been constantly increasing.
Metabolic pathways are groups of metabolites that are related
to the same biological process, and that are directly or indirectly
connected by one or multiple enzymatic reactions. Biological data-
bases such as Kyoto Encyclopedia of Genes and Genomes (KEGG;
Kanehisa et al., 2012), small molecule pathway database (SMPDB;
Jewison et al., 2014), EHMN (Ma et al., 2007), WikiPathways
(Kelder et al., 2012), and MetaCyc (Caspi et al., 2008) provide
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Table 2 | Spectral databases available for metabolite identification.
Database Spectral
data
Website Statistics Reference
HMDB MS/NMR http://www.hmdb.ca 41,806 metabolite entries and 1,579 metabolites
with spectra (1H-NMR, LC-MS, GC-MS . . .)
Wishart et al. (2013)
LMSD MS http://www.lipidmaps.org 37,500 lipid structures with MS/MS spectra Sud et al. (2007)
METLIN MS http://metlin.scripps.edu 240,516 metabolite entries and 12,057 metabolites
with MS/MS spectra
Tautenhahn et al. (2012a)
TOCCATA
COLMAR
NMR http://spin.ccic.ohio-state.edu Multiple spectral NMR datasets: 1H- and 13C-NMR,
2D 13C–13C TOCSY (n=463), 2D 1H–1H TOCSY
and 13C–1H HSQC-TOCSY (n=475), and 2D
13C–1H HSQC (n=555)
Robinette et al. (2008),
Bingol et al. (2012, 2014,
2015)
MassBank MS http://www.massbank.jp 2,337 metabolites and 40,889 spectra (LC-MS,
GC-MS . . .)
Horai et al. (2010)
Golm metabolome GC-MS http://gmd.mpimp-golm.mpg.de 2,019 metabolites with GC-MS spectra Hummel et al. (2007)
BMRB NMR http://www.bmrb.wisc.edu 9,841 biomolecules with 1H, 13C, or 15N spectra Ulrich et al. (2008)
Madison NMR http://mmcd.nmrfam.wisc.edu 794 compounds with spectra including 1H, 13C,
1H–1H, 1H–13C . . .
Cui et al. (2008)
NMRShiftDB NMR http://nmrshiftdb.nmr.uni-koeln.de 42,840 structures and 50,897 measured spectra Steinbeck et al. (2003)
RIKEN MS/NMR http://prime.psc.riken.jp 1,589 metabolites (Arabidopsis) Akiyama et al. (2008),
Sakurai et al. (2013)
Birmingham
Metabolite Library
NMR http://www.bml-nmr.org 208 metabolites and 3,328 1D- and 2D-NMR
spectra
Ludwig et al. (2012)
This table shows a list of the spectral databases that are most commonly used in current metabolomics studies to characterize the associated metabolite features.
exhaustive information of a large number of metabolic pathways
(Table 3). The availability of this data is therefore enabling the
use of pathway-based approaches in metabolomics. These meth-
ods are currently referred as metabolite set enrichment analysis
(MSEA), and are methodologically based on the gene set enrich-
ment analysis (GSEA) approach, designed for pathway analysis of
gene-expression data (Khatri et al., 2012).
To date, three different approaches have been developed to
perform MSEA (Xia and Wishart, 2010b):
• Overrepresentation analysis (ORA): Given a list of metabolite
pathways or groups of metabolites of interest, a hypergeomet-
ric test or a Fisher’s Exact test is used to evaluate whether the
metabolites of these groups are represented more than expected
by chance. When the input metabolite list is defined as the set
of metabolites which are differentially expressed in the analyzed
phenotypes, the ORA results may identify metabolic pathways
that are globally associated to these phenotypes.
• Quantitative enrichment analysis (QEA): Unlike ORA, the input
data for this method is a set of metabolite concentrations
from multiple samples. Enriched pathways can be identified
using different approaches like globaltest (Goeman et al., 2004),
globalAncova (Hummel et al., 2008), or the Wilcoxon-based
test (Adjaye et al., 2005). Enriched pathways include pathways
where a few number of compounds are significantly changed or
pathways where a large number of metabolites are slightly but
consistently changed (Xia and Wishart, 2010b).
• Single-sample profiling (SSP): While the two previous methods
are suited for studies involving large numbers of samples, this
approach can be used at the sample level. The input data for SSP
analysis is an input list of normalized metabolite concentrations
in a common biofluid, tissue, or cell type and a database with the
normal concentration ranges of these metabolites in the sample.
From this input data, SSP identifies the set of metabolites show-
ing levels significantly different from the normal concentration
ranges.
In order to improve the interpretability of pathway analysis
results, MSEA results can be combined with pathway topologi-
cal measures. These measures allow the assessment of impact of
the unbalanced metabolites within the overrepresented pathway.
First, single impacts are evaluated using the degree and between-
ness network centrality measures of each metabolite (Aittokallio
and Schwikowski, 2006). Subsequently, the overall impact (i.e.,
pathway impact; Xia and Wishart, 2010a) is calculated as the sum
of the single impact measures of the unbalanced metabolites nor-
malized by the sum of the impact measures of all the metabolites
within the pathway.
Metabolomics researchers currently have a wide variety of soft-
ware tools to analyze metabolomic data at the pathway level.
Applications such as Paintomics (García-Alcalde et al., 2011),
Vanted (Rohn et al., 2012), and Cytoscape (Smoot et al., 2011)
provide different pathway visualization tools. In these tools, the
metabolites are mapped on predefined metabolic pathways, and
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Table 3 | Biological databases for pathway analysis.
Database Description Website Reference
Kyoto Encyclopedia of Genes and
Genomes (KEGG)
466 pathways, 17,333 metabolites, and 9,764
biochemical reactions
http://www.genome.jp/kegg/ Kanehisa et al. (2012)
MetaCyc 2260 pathways from 2600 different organisms http://metacyc.org/ Caspi et al. (2008)
The small molecule pathway database
(SMPDB)
1,594 metabolites mapping 727 small molecule
pathways found in humans
http://www.smpdb.ca/ Jewison et al. (2014)
WikiPathways 1,910 pathways http://wikipathways.org/ Kelder et al. (2012)
Plant metabolic network
(PMN/PlantCyc)
Multi-species pathway database for plant
metabolomics
http://www.plantcyc.org/ Chae et al. (2014)
This table describes the main databases that provide biological information on metabolites and metabolic pathways.
allow a high level of interaction with the data. In addition to
visualization tools, Impala (Kamburov et al., 2011) and MetScape2
(Karnovsky et al., 2012) are software tools that also implement spe-
cific MSEA methods. Finally, Metaboanalyst is a highly versatile
pathway analysis tool, providing a wide range of MSEA methods
as well as topological and visualization tools (Xia et al., 2012).
CORRELATION-BASED NETWORK ANALYSIS
One of the main features of biologic data is the high level of correla-
tion existing between the different elements (i.e., mRNAs, proteins,
metabolites). Part of these relational patterns is due to metabolites
that belong to common metabolic pathways. In other cases, how-
ever, the observed correlations may be due to other causes like
global perturbations (i.e., metabolic compounds showing diur-
nal variation in time series analysis), specific perturbations (i.e.,
changes in enzyme concentrations spread through their related
metabolic pathways), or the intrinsic variability of metabolomic
data (Steuer et al., 2003; Camacho et al., 2005; Steuer, 2006). Con-
sequently, metabolites that do not show significant differences
across the studied phenotypes may still show different correlation
patterns with other metabolites in each phenotype. These patterns
can provide valuable information about the underlying metabolic
network associated to a specific biological process (Steuer, 2006).
Unlike pathway analysis, correlation-based methods build
metabolite networks according to the relationship patterns
observed in the experiment data. In the resulting network, each
metabolite is represented by a network node but, in contrast
to pathway analysis, the links between nodes represent the level
of mathematical correlation between each pair of metabolites.
In metabolomics data, high correlation coefficients are frequent
due to the presence of systemic and indirect associations (Krum-
siek et al., 2011). Using classical correlation coefficients leads
to highly crowded networks where direct and indirect associa-
tions are not distinguished (Langfelder and Horvath, 2008). This
problem can be successfully overcome using partial correlation
(Krumsiek et al., 2011; Valcárcel et al., 2011). In this approach, the
correlation between two metabolites is conditioned against the
correlation with the remaining metabolites. Consequently, par-
tial correlation allows to discriminate between direct and indirect
(i.e., mediated by other metabolites) metabolite correlations. Val-
cárcel et al. used this approach to build two different networks
corresponding to individuals with normal fasting glucose and
individuals with prediabetes (Valcárcel et al., 2011). Although
few differences were found between individual metabolite con-
centrations, the network analysis performed in this study revealed
significant changes in lipoprotein metabolism, which is known to
be associated with diabetes pathophysiology. Netzer et al. used
a similar approach to identify highly discriminant metabolites
between healthy controls and individuals with obesity (Netzer
et al., 2012). In this case, the metabolic network was built using
Pearson’s correlation coefficient, and the differential metabolites
were evaluated by using different network descriptors. In the same
study, Netzer et al. used the metabolic differences between two
sample groups to build a metabolite ratio network (Netzer et al.,
2011). In this approach, the link between two metabolites is scored
according to the differences in the ratios between the correspond-
ing metabolites in the two sample groups. The resulting network
topology is then based on the metabolic differences between the
two studied phenotypes. Recently, Kotze et al. have extended the
correlation-based network approach to include prior biological
knowledge (Kotze et al., 2013). In this approach, the resulting
network is mapped onto known metabolic pathways in order to
identify novel links within the metabolic network that may play a
key role in the phenotypic trait being studied.
INTEGRATION OF OMICS DATA
Systems biology is the computational modeling of complex bio-
logical systems at different molecular levels through the analysis
of high-throughput data. Systems biology methods can therefore
improve our understanding of the biological processes that are
associated with a certain phenotype. These approaches also allow
studying how the dysregulation of specific biological pathways is
propagated across the biological system. The characterization of
the complex and often noisy biological systems has become a major
challenge in bioinformatics.
METABOLOMICS INTEGRATION WITH WHOLE GENOME VARIATION
The association between genome-wide genetic variation and high-
throughput metabolomic data is one of the current main objec-
tives of omics data integration. The joint analysis of both types
of biological data, known as metabolite genome-wide association
studies (mGWAS), has allowed the identification of a large num-
ber of genomic regions associated with metabolite levels (Gieger
et al., 2008; Illig et al., 2010; Suhre et al., 2011a,b; Table 4). These
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Table 4 | List of studies integrating genomics and metabolomics data.
Cohort sizea Metabolites Biofluid Metabolomics platform Objectives Reference
284 363/40401 Serum ESI-MS/MS Study of GIMs Gieger et al. (2008)
4400 33 Plasma ESI-MS/MS Study of GIMs Hicks et al. (2009)
1809/422 163 Serum ESI-MS/MS Study of GIMs Illig et al. (2010)
1814 163 Serum ESI-MS/MS Study of GIMs Kolz et al. (2009)
862/2031 59 Urine NMR Study of GIMs Suhre et al. (2011b)
1768/1052 276 Serum UHPLC/MS/MS2, GC/MS Study of GIMs and overlap with loci of
biomedical and pharmaceutical interest
Suhre et al. (2011a)
211 526 Urine and
plasma
Multi-platform Study of GIMs and decomposition of
biological population variation in metabolic
traits
Nicholson et al. (2011)
4034 153 Plasma ESI-MS/MS Study of GIMs and pathway analysis Demirkan et al. (2012)
8330 216 Serum NMR Study of GIMs and heritability of metabolic
traits
Kettunen et al. (2012)
6600 130 Serum NMR Study of metabolic associations with
atherosclerosis using metabolic networks
Inouye et al. (2012)
2076 217 Plasma HPLC/MS Study of GIMs and heritability of metabolic
traits
Rhee et al. (2013)
7824 486 Plasma UHPLC/MS/MS2, GC/MS Study of GIMs, heritability of metabolic
traits, and network analysis
Shin et al. (2014)
This table provides an updated list of studies that have integrated metabolomics data with genomics data.
aStudies with discovery and validation cohorts are given as Ndiscovery/Nvalidation.
associations are commonly called genetically influenced metabo-
types (GIMs), and could play an important role in the heritability
of phenotypic traits. The association between genetic variants and
phenotypic traits that often show small association effect sizes can
be significantly increased when using intermediate phenotypes
like metabolite concentrations (Gieger et al., 2008). These inter-
mediate phenotypes (or endophenotypes) may be characterized by
larger effect size associations since they are continuous variables
that reflect the actual state of the biological system.
One of the main statistical problems when analyzing the asso-
ciation between genetic variants and metabolite concentrations
at a genome-wide level is the large number of tests that must be
performed. The number of genetic variants analyzed for each indi-
vidual by the current high-throughput genotyping technologies
usually ranges between 500,000 and 2e6. This number of genomic
variants can be further increased up to 5–10e6 variants with the
help of imputation techniques (Howie et al., 2009; Delaneau et al.,
2013). Compared to gene-expression data, metabolomic profiles
have a much lower number of variables, ranging from 100 s to
few 1,000 s. Nevertheless, performing all gene to metabolite asso-
ciation analyses in mGWAS can result in up to 1 · 107–1 · 1011
statistical tests. To date, there are multiple tools that can effi-
ciently perform this large number of quantitative trait analysis
like Matrix eQTL (Shabalin, 2012). However, the main limitation
of this type of studies is the number of tests that are performed
in parallel, and the associated increase in the false positive rate at
the nominal (α= 0.05) level of significance. Applying a conserva-
tive multiple test correction methods like the Bonferroni method
leads to extremely high significance thresholds (i.e., corrected α
levels= 1 · 10−9–1 · 10−13, depending on the total number of per-
formed tests; Gieger et al., 2008; Illig et al., 2010). In order to
set a less stringent correction threshold for this type of studies,
Demirkan et al. computed the effective number of independent
tests by using the number of significant principal components
of variation of the metabolomic data (Demirkan et al., 2012).
Other studies instead have chosen the genome-wide level of signif-
icance commonly used in single-trait GWAS (α= 5e−8; McCarthy
et al., 2008; Kolz et al., 2009; Tanaka et al., 2009; Rhee et al.,
2013).
While most published mGWAS have relied on univariate associ-
ation tests, there is an increasing effort to develop new multivariate
approaches. These approaches have been designed to simultane-
ously analyze sets of metabolites instead of individual metabolite
levels (Klei et al., 2008; Ferreira and Purcell, 2009; O’reilly et al.,
2012; Ried et al., 2012; Stephens, 2013). These new approaches
have several advantages (Galesloot et al., 2014):
• They take into account the pleiotropic nature of metabolomic
data. Subsequently, a genetic variant can be simultaneously
associated with multiple metabolites.
• When a genetic variant is associated with multiple metabo-
lites, the aggregated information of the entire set of metabolites
increases the statistical power of the analysis (Allison et al., 1998;
Zhu and Zhang, 2009).
• By performing a single test for each set of metabolites, the
multiple test burden is reduced.
However, one of the main disadvantages of this type of analy-
sis methods is the reduced number of metabolites that can be
tested simultaneously. This implies that current metabolite pan-
els (>100 metabolites) cannot be tested together. Inouye et al.
overcame this problem by using a two-step design (Inouye et al.,
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2012). First, using the metabolite correlation matrix they identified
the most relevant metabolic networks using hierarchical cluster-
ing. The second step consisted of a multivariate GWAS of each
selected network. Each genomic variant was therefore tested a
much reduced amount of times and, for each test, the loading
of each network metabolite was computed.
Pathway-based approaches are also an important approach for
the analysis of genetic variation associated with metabolite levels.
As described in Section “Correlation-Based Network Analysis,” the
methods based on partial correlation coefficients are optimal for
the analysis of metabolomic data (Krumsiek et al., 2011). One of
these methods, Gaussian Graphical Modeling (GGM), has been
recently used to identify unknown metabolites through the inte-
gration of metabolomics, GWAS, and pathway data (Krumsiek
et al., 2012). Recently, Shin et al. also used GGM to build a com-
plete network of genetic variation associated with human blood
metabolite levels (Shin et al., 2014).
METABOLOMICS INTEGRATION WITH OTHER OMICS SCIENCES
Recently, the first study analyzing the association of the genome
methylation patterns methylation with metabolic traits has been
performed (Petersen et al., 2014). In this study, Petersen et al.
used multivariate regression analyses to identify two types of
methylome–metabotype associations: (a) associations due to
underlying genetic variants and (b) independent associations
potentially driven by environmental factors influencing the methy-
lome.
In addition to mGWAS studies, several studies have also
explored the association between whole genome gene-expression
(i.e., transcriptomics) and metabolomics. The data provided by
these two omics sciences have been used, for example, to improve
the classification of breast cancers and to explore the correlation
between the transcriptional and metabolic levels (Borgan et al.,
2010). Borgan et al. used the transcriptional data to classify the
breast tumor samples according to previously published tumor
types. In a second step, they applied hierarchical clustering on each
type of samples using the metabolic data. Using this combined
approach, new molecular subtypes of tumors were found. Impor-
tantly, these new molecular subtypes were better classified than
subtypes based only on gene-expression patterns. Additionally,
new biological pathways associated with each molecular subtype
could be identified. Using GOrilla software (Eden et al., 2009), they
were able to identify potential gene groups regulating each ana-
lyzed metabolite. Bjerrum et al. recently combined transcriptomics
and metabolomics data from colon biopsies of ulcerative colitis
patients. They used O-PLS-DA and multivariate logistic regres-
sion models to improve the diagnosis of this autoimmune disease
(Bjerrum et al., 2014). Zhang et al. also integrated transcriptomics
and metabolomics data to study human pancreatic cancer samples
(Zhang et al., 2013). Using a correlation-based network analysis,
they identified a set of highly co-regulated and decreased metabo-
lites in these samples and subsequently identified the transcripts
correlated with these metabolites.
TOWARD A COMPLETE OMICS INTEGRATION
During the last years, high-throughput technologies have enabled
the analysis of the biologic variability at multiple molecular levels.
The data obtained from the genome, epigenome, transcriptome,
proteome, metabolome, or the microbiome can be now combined
using systems biology approaches. However, this group of ana-
lytical tools is still in its infancy and major improvements in this
field will come in the next years (Chen et al., 2012). 3Omics is
one good example of this new type of metabolomic analysis tools.
3Omics is one of the first systems biology tools to provide a full
integrative analysis including correlation analysis, co-expression
profiling, phenotype mapping, pathway enrichment analysis, and
GO enrichment analysis at three molecular levels (transcriptome,
proteome, and metabolome; Kuo et al., 2013).
CONCLUSION
Metabolomics is a research field rapidly evolving to allow the fast
and accurate analysis of high-throughput data from diverse biolog-
ical sources. Although the recent methodologies have been able to
overcome several challenges of metabolomics data analysis, there
is still much room for improvement. In untargeted metabolomic
studies, for example, major improvements are still required in
automatic metabolite identification and spectral deconvolution.
Although a big effort is being done to improve spectral databases,
the development of accurate automatic identification algorithms
is still subject to the availability of an exhaustive set of reference
metabolite spectra.
In addition to the necessary improvements in the analysis work-
flow, intense efforts are also being done in the standardization
of metabolomics data (Salek et al., 2013a). The Metabolomics
Standard Initiative (MSI; Fiehn et al., 2007), currently represents
the major community effort to define normalization standards
in metabolomics. These developments are based on previous
high-throughput data standardization initiatives like MIAME in
microarray studies (Brazma et al., 2001), and include the use
of minimal reported information, common syntax, data format
exchange, and common semantics (Field and Sansone, 2006). To
date, general guidelines have been proposed (Sumner et al., 2007)
that cover relevant areas in metabolomics studies like biologi-
cal sample processing, analytical technique details (i.e., instru-
ment description, technique-specific acquisition parameters, and
sample preparation), instrumental calibration, validation of the
quantification method, data pre-processing, metabolite identifica-
tion, and nomenclature. Very recently, the MetaboLights database
(www.ebi.ac.uk/metabolights) has been launched as a reposi-
tory to archive and distribute data on metabolomics experiments
(Steinbeck et al., 2012; Haug et al., 2013; Salek et al., 2013b).
Similar to the established public repositories of transcriptomics
data (Barrett et al., 2011), the availability of public repositories
for metabolomics data will clearly accelerate the progress in this
rapidly evolving field.
Omics sciences like metabolomics are increasing our ability to
generate knowledge from multiple aspects of biology. In order to
achieve these goals, however, the scientific community will require
tools and methods that are able to efficiently integrate all the dif-
ferent sources of molecular and phenotypic information. In the
near future, increasingly powerful analysis tools will be developed.
The access to these methods in an open-source environment will
guarantee its dissemination to the largest scientific community
possible.
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